• Curis Inc CRIS.OQ reported a quarterly adjusted loss of $1.25​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-2.05. The mean expectation of four analysts for the quarter was for a loss of $1.19 per share. Wall Street expected results to range from $-1.39 to -96 cents per share.

• Revenue rose 14.1% to $2.38 million from a year ago; analysts expected $2.60 million.

• Curis Inc's reported EPS for the quarter was a loss of $1.25​.

• Curis Inc shares had risen by 16.7% this quarter and lost 19.9% so far this year.

FORECAST CHANGES

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Curis Inc is $16.00

This summary was machine generated from LSEG data May 7 at 02:14 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)